![]() | ![]() |
Formats:
|
||||||||||||||||||||||||||||||
Copyright This is an Open Access article: verbatim copying and redistribution of
this article are permitted in all media for any purpose, provided this
notice is preserved along with the article's original DOI Research Satratoxin G from the Black Mold Stachybotrys chartarum Evokes Olfactory Sensory Neuron Loss and Inflammation in the Murine Nose
and Brain 1 Center for Integrative Toxicology 2 Department of Microbiology and Molecular Genetics 3 Department of Food Science and Human Nutrition and 4 Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, Michigan, USA Address correspondence to J.J. Pestka, 234 G.M. Trout Building, Michigan
State University, East Lansing, MI 48824 USA. Telephone: (517) 353-1709. Fax: (517) 353-8963. E-mail: pestka/at/msu.edu The authors declare they have no competing financial interests. Received November 14, 2005; Accepted February 27, 2006. See "A Killer Smell: Mold Toxin Destroys Olfactory Cells in Mice" on page A428b. This article has been cited by other articles in PMC.Abstract Satratoxin G (SG) is a macrocyclic trichothecene mycotoxin produced by Stachybotrys chartarum, the “black mold” suggested to contribute etiologically
to illnesses associated with water-damaged buildings. Using an intranasal
instillation model in mice, we found that acute SG exposure specifically
induced apoptosis of olfactory sensory neurons (OSNs) in the
olfactory epithelium. Dose–response analysis revealed that the
no-effect and lowest-effect levels at 24 hr postinstillation (PI) were 5 and 25 μg/kg
body weight (bw) SG, respectively, with severity
increasing with dose. Apoptosis of OSNs was identified using immunohistochemistry
for caspase-3 expression, electron microscopy for ultrastructural
cellular morphology, and real-time polymerase chain reaction
for elevated expression of the proapoptotic genes Fas, FasL, p75NGFR, p53, Bax, caspase-3, and CAD. Time-course studies with a single instillation of SG (500 μg/kg
bw) indicated that maximum atrophy of the olfactory epithelium occurred
at 3 days PI. Exposure to lower doses (100 μg/kg bw) for 5 consecutive
days resulted in similar atrophy and apoptosis, suggesting
that in the short term, these effects are cumulative. SG also induced
an acute, neutrophilic rhinitis as early as 24 hr PI. Elevated mRNA
expression for the proinflammatory cytokines tumor necrosis factor-α, interleukin-6 (IL-6), and IL-1 and the chemokine macrophage-inflammatory
protein-2 (MIP-2) were detected at 24 hr PI in both the ethmoid
turbinates of the nasal airways and the adjacent olfactory bulb of
the brain. Marked atrophy of the olfactory nerve and glomerular layers
of the olfactory bulb was also detectable by 7 days PI along with mild
neutrophilic encephalitis. These findings suggest that neurotoxicity
and inflammation within the nose and brain are potential adverse health
effects of exposure to satratoxins and Stachybotrys in the indoor air of water-damaged buildings. Keywords: apoptosis, fungus, inflammation, inhalation, mycotoxin, neurotoxicity, olfactory sensory neuron, rhinitis, trichothecene Numerous adverse human health effects have been attributed to damp indoor
air environments generated by aberrant water exposure due to excessive
condensation and failure of water-use devices, as well as building
envelope breach during heavy rains or flooding, as occurred during Hurricanes
Katrina and Rita on the Gulf Coast of the United States. An Institute
of Medicine (IOM) expert panel concluded that an association
exists between damp buildings and upper respiratory tract symptoms, wheeze, cough, and
exacerbation of chronic lung diseases such as asthma, whereas
supportive data for other reported outcomes such as neurocognitive
dysfunction, mucous membrane irritation, fatigue, fever, and immune
disorders are lacking (IOM 2004). Building-related illnesses are often linked to dampness-promoted growth
of fungi (Fog Nielsen 2003) and, most notably, Stachybotrys chartarum, a saprophytic “black mold” that grows on cellulosic materials, including
wall-board, ceiling tiles, and cardboard (Hossain et al. 2004). Incidences of indoor S. chartarum contamination often generate costly litigation and remediation, are extensively
reported by the media, and have evoked intense public and scientific
controversy (Hardin et al. 2003). The IOM panel suggested that although in vitro and in vivo research on S. chartarum and its mycotoxins suggests that adverse effects in humans are indeed “biologically
plausible,” their association with building-related
illnesses requires rigorous validation from the perspectives
of mechanisms, dose response, and exposure assessment (IOM 2004). The satratoxins, macrocyclic trichothecenes produced by S. chartarum, are potent inhibitors of protein translation that initiate both inflammatory
gene expression and apoptosis in vitro after upstream activation of mitogen-activated protein kinases (MAPKs) (Chung et al. 2003; Yang et al. 2000). Satratoxin equivalent airborne concentrations ranging from 2 to 34 ng/m3 (Yike et al. 1999) and from 54 to 330 ng/m3 (Vesper et al. 2000) have been previously estimated, by a translational bioassay, to occur
in rooms of water-damaged homes heavily contaminated with Stachybotrys. These water-soluble mycotoxins occur in the outer plasmalemma surface
and the inner wall layers of conidiospores (Gregory et al. 2004) as well as in nonviable airborne particulates (Brasel et al. 2005), which could facilitate entry and release into respiratory airway tissue. Indeed, pulmonary
toxicity of the spores of S. chartarum and associated trichothecenes has been demonstrated in animal studies
using intranasally or intratracheally exposed laboratory rodents (Yike and Dearborn 2004; Yike et al. 2005). Under normal resting, nonexercising conditions, the nose functions to filter, warm, and
humidify inhaled air before it enters more delicate airway
and alveolar tissues in the distal lung (Cole 1993). Nasal passages serve as “scrubbing towers” for the respiratory
tract by efficiently a) absorbing water-soluble and reactive gases and vapors, b) trapping inhaled particles, and c) metabolizing airborne xenobiotics (Harkema 1991). Given these air conditioning and defensive roles, we hypothesized that
the nasal airways are another critical site for interaction with S. chartarum mycotoxins. To test this hypothesis, we employed a murine intranasal instillation
model previously used by our laboratory and others to study
the adverse effects of harmful toxic agents (Giannetti et al. 2004), allergens (Farraj et al. 2004), and pathogens (Wiley et al. 2001) to investigate potential nasal toxicity of satratoxin G (SG), one of
the most potent trichothecenes produced by S. chartarum (Yang et al. 2000). Materials and Methods Toxins SG and isosatratoxin F (ISF) were purified from S. chartarum cultures and kindly provided by B. Jarvis (University of Maryland, College
Park, MD). SG and ISF yielded a single peak at 254 nm by the HPLC
method of Hinkley and Jarvis (2001). SG and ISF identities were further confirmed by electrospray ionization/collision-induced
dissociation (ESI-CID) tandem mass spectroscopy at
the Michigan Sate University mass spectrometry facility by a modification
of a published method (Tuomi et al. 1998) using a LCQ-DECA device (Finnigan, San Jose, CA) fitted with an ESI probe. Deoxynivalenol, T-2 toxin, and verrucarin A (Sigma Chemical Co., St. Louis, MO) had
reported purities of > 98%, 98%, and 95%, respectively. Laboratory animals and intranasal instillation Mice were maintained under humane conditions according to National Institutes
of Health guidelines (Institute of Laboratory Animal Resources 1996) as overseen by the All University Committee on Animal Use and Care at
Michigan State University. Pathogen-free female C57Bl/6 mice (7–8 weeks
of age; Charles River, Portage, MI) were randomly assigned
to experimental groups (n = 5–6) and housed in polycarbonate cages containing Cell-Sorb
Plus bedding (A & W Products, Cincinnati, OH) covered with
filter bonnets and provided free access to food and water. Room lights
were set on a 12-hr light/dark cycle, and temperature and relative humidity
were maintained between 21 and 24°C and 40 and 55%, respectively. For
each experiment, mice were anesthetized with 4% halothane
and 96% oxygen and then instilled intranasally
at 50 μL/mouse with SG or other trichothecenes dissolved
in a vehicle of pyrogen-free saline (Abbott Laboratories, Abbott Park, IL) or
with the vehicle alone. Animal necropsies and tissue processing for light microscopic examination For histopathology and morphometry, mice were deeply anesthetized via intraperitoneal (ip) injection of 0.1 mL of 12% sodium pentobarbital
in saline at designated times post-instillation (PI), from 6 hr
to 28 days, and killed via exsanguination by cutting the abdominal aorta
or renal arteries. Heads from each mouse were immediately removed, and 1 mL
of 10% neutral buffered formalin (Fisher Scientific Co., Fairlawn, NJ) was
flushed retrograde through the nasopharyngeal meatus. After
the lower jaw, skin, muscles, eyes, and dorsal cranium were
removed, the head with brain intact was immersed and stored in a large
volume of the fixative for at least 48 hr before further tissue processing. Lungs
were also removed and intratracheally perfused with formalin
fixative at a constant pressure of 30 cm of water for approximately 1 hr
and then similarly immersed and stored for a minimum 48 hr. After fixation, transverse tissue blocks from the head and left lung lobe
of these mice were selected for light microscopy as previously described (Steiger et al. 1995). Before sectioning, the heads were decalcified in 13% formic
acid for 7 days and then rinsed in tap water for at least 4 hr. The nasal
cavity of each mouse was transversely sectioned at four specific anatomic
locations, designated T1–T4 (Mery et al. 1994; Young 1981). The most proximal nasal section was taken immediately posterior to the
upper incisor teeth (proximal, T1); the middle section was taken at
the level of the incisive papilla of the hard palate (middle, T2); the
third nasal section was taken at the level of the second palatal ridge (T3); and
the most distal nasal section (T4) was taken at the level
of the intersection of the hard and soft palate and through the proximal
portion of the olfactory bulb (OB) of the brain (Figure 1
Immunohistochemistry Unstained and hydrated paraffin sections from nasal blocks T3 and T4 were
incubated first with a nonspecific protein-blocking solution containing
normal sera (Vector Laboratories Inc., Burlingame, CA) and then with
specific dilutions of primary polyclonal antibodies directed against
activated caspase-3 (1:100, rabbit anti-caspase-3 antibody; Abcam, Inc., Cambridge, MA), olfactory marker protein (OMP; 1:4,000, goat anti-OMP
antibody, provided by F. Margolis, University of Maryland), or infiltrating
neutrophils (1:600, rabbit anti-rat neutrophil antibody, provided
by R. Roth, Michigan State University). Tissue sections used for
caspase-3 or OMP detection were pretreated before the blocking solution
with 3% hydrogen peroxide in methanol to destroy endogenous
peroxidase. With these tissue sections, the primary antibody was followed
by the secondary antibody, biotinylated anti-species IgG. Immunoreactivity
of caspase-3 and OMP was visualized with Vector R.T.U. Elite
ABC-Peroxidase Reagent followed by Nova Red (Vector Laboratories Inc.) as
the chromagen. Anti-neutrophil antibody treatment was followed
by biotinylated anti-rabbit IgG, and then streptavidin-phosphatase complex (KPL
laboratories, Gaithersburg, MD) and Vector red as the chromagen. After
immunohistochemistry, slides were lightly counterstained with
hematoxylin. Semiquantitative scoring of nasal histopathology Nasal sections from mice that received a single instillation of SG at various
doses and were sacrificed 24 hr PI were scored for the amount of
toxin-induced, light microscopic lesions in the olfactory epithelium (OE). A
veterinary pathologist, without previous knowledge of exposure
history of the individual mice, ranked severity of SG-induced OE apoptosis
with atrophy in the examined nasal tissue sections (T1–T4) using
the following histopathologic numeric scores: 0, no SG-induced
nasal lesions in OE; 1 (minimal), 25% of OE with lesions; 2 (mild), 25–50% of OE with lesions; 3 (moderate), 50–75% of
OE with lesions; or 4 (marked), ≥ 75% of
OE with lesions. Light microscopic morphometry Thickness of the OE lining the medial surface of the second ethmoid turbinates (2E) in
T3 (Figure 1
where Pp is the point fraction of Pn, the number of test points hitting the structure of interest, divided
by Pt, the total points hitting the reference space (OE). The volume of the
epithelial component of interest (e.g., apoptotic nuclei) per unit of
basement membrane (Sv) was determined by point and intercept counting and was calculated using
the following formula:
where Io is the number of intercepts with the object (epithelial basal lamina) and Lr is the length of test line in the reference volume (epithelium). To determine
thickness of the OE, a volume per unit area of basal lamina (cubic
micrometers per square micrometer) was then calculated using the
following formula for arithmetic mean thickness (τ):
Other standard morphometric and image analysis techniques were used to
determine the numeric cell density of mature olfactory sensory neurons (OSNs) in
OE. Morphometric estimates of the numeric cell density of OSNs
immunohistochemically reactive for OMP (protein indicator of mature
OSNs) were determined via light microscopy (790× final magnification) by
counting the number of nuclear profiles of these immunoreactive
neuroepithelial cells in the OE lining the medial surface of 2E
in T3 (Figure 1 Ultrastructural examination of the olfactory mucosa and OB via transmission
electron microscopy Mice designated for transmission electron microscopy (TEM) analysis were
anesthetized with an ip injection of 0.1 mL 12% pentobarbital
containing 1 IU heparin. Immediately after anesthesia, the whole body
received an intravascular perfusion via the left heart with a saline
solution containing 10 IU heparin for 2–3 min, followed by a 7–10 min
perfusion with 4% glutaraldehyde fixative solution (Ted
Pella, Inc., Redding, CA). The nasal cavity and brain were
then removed and stored in the fixative until TEM processing after the
nasal cavity was decalcified with 10% EDTA for 3–4 weeks; selected
tissues from ethmoid turbinates and OB were postfixed in 1% phosphate-buffered osmium tetroxide, dehydrated through a
graded series of ethanol and propylene oxide, and embedded in Poly/Bed-Araldite
resin (Polysciences, Inc., Warrington, PA). Sections (1 μm) were
cut and stained with toluidine blue for light microscopic
identification of tissue sites for TEM. Ultrathin tissue sections for
TEM were cut at approximately 75 nm with a diamond knife, mounted on
copper grids, and stained with lead citrate and uranyl acetate. Sectioning
was done with an LKB Ultratome III (LKB Instruments, Inc., Rockville, MD). Ultrastructural
tissue examination and photography were performed
with a JEOL JEM 100CXII electron microscope (JEOL Ltd., Tokyo, Japan). Real-time polymerase chain reaction Mice used for polymerase chain reaction (PCR) analyses of nasal and brain
tissues were anesthetized and killed at designated times after SG instillation
as described above. Immediately after death, the head of each
mouse was removed from the carcass; after the skin, muscles, eyes, and
lower jaw were removed from the head, the nasal airways were opened
by splitting the nose in a sagittal plane adjacent to the midline. The
nasal septum was removed, thereby exposing the nasal turbinates projecting
from the lateral wall of each nasal passage (Figure 1 Statistics All data were analyzed with SigmaStat (version 3.1; Jandel Scientific, San
Rafael, CA) with the criterion for significance set at p < 0.05. Morphometric and RT-PCR data were statistically analyzed using
one-way analysis of variance with Student-Newman-Keuls posttest. Data
from histopathologic severity scores of SG-induced lesions were analyzed
using the Mann Whitney rank sum test (nonparametric test) with
Bonferroni correction for multiple comparisons. Results OE targeted by nasal SG exposure Light microscopic evaluation of four specific anatomical sites (T1–T4) revealed
that mice exposed to SG [500 μg/kg body
weight (bw)] and sacrificed at 1, 3, or 7 days PI had conspicuous
nasal epithelial and inflammatory lesions in the dorsocaudal half
of the nasal passages that is normally lined by OE. These lesions were
not apparent in the nasal cavity of saline vehicle–treated
controls (Figure 1A Apoptosis induction in OE Dose–response analysis of SG-induced apoptotic lesions indicated
that the no-effect level was 5 μg/kg bw (80 ng/mouse) and the
lowest effect level was 25 μg/kg bw (400 ng/mouse; Figure 2
SG-mediated OE atrophy Concurrent with SG-induced OSN apoptosis, OE atrophy was detectable at 1 day
PI (Figure 4A
Role of trichothecene structure in OE atrophy The nasal effects of trichothecenes not associated with Stachybotrys were also assessed. Mice intranasally exposed to deoxynivalenol, T-2, and
verrucarin A, which are type A, type B, and macrocyclic trichothecenes, respectively, using
doses of equivalent to one-third to one-fifth
of LD50 values (doses lethal in 50% of test animals) (Ueno 1984). These trichothecenes had no effect on OE compared with the Stachybotrys mycotoxins SG and ISF, which exhibited robust toxicity (Figure 5A
Selective apoptosis induction in OSNs OMP, a specific peptide found only in mature OSNs (Kream and Margolis 1984), was markedly reduced in the OE of SG-instilled mice compared with saline-instilled
control mice (Figure 6A–C
Concurrent with the initial loss of OMP-positive OSNs, there was also noticeable
atrophy of the OMP-positive olfactory nerve bundles located
in the lamina propria underlying the atrophic OE (Figure 6B
Inflammatory gene up-regulation and neutrophil infiltration in OE and OB At 1 day PI, SG also induced conspicuous accumulations of exfoliated and
degenerating cellular debris from the dendritic portions of the apoptotic
OSNs in the nasal airways along the luminal surfaces of the atrophying
OE. With secondary degeneration of these exfoliated dendritic fragments, there
was accompanying infiltration of numerous phagocytic cells
consisting mainly of polymorphonuclear leukocytes (neutrophils) and
only occasional mononuclear cells (monocytes and macrophages). Many
of the luminal neutrophils had engulfed apoptotic cellular fragments (Figures 3C
Slightly decreased severity of SG-induced neutrophilic rhinitis corresponded
with time-dependent disappearance of epithelial apoptosis and development
of epithelial atrophy. A mild-to-moderate influx of neutrophils
persisted in the lamina propria of the affected nasal mucosa underlying
the atrophic OE even at 7 days PI (Figure 8C
Discussion The causes of damp-building syndrome are likely to be multifactorial and
involve toxic, inflammatory, and allergic responses to microbes and
their products; however, the underlying mechanisms, relative contributions
of individual organisms, and potential for interactions remain poorly
understood (IOM 2004). Although exposure to either S. chartarum spores or associated satratoxins has been previously shown to initiate
acute inflammatory responses in the rodent lung (Yike and Dearborn 2004), our observations that very low doses of SG are directly toxic to OSNs
and initiate an inflammatory response in the nose (rhinitis) that extends
into the brain (mild focal encephalitis) (Figure 10
Like other epithelial cells in the body, but unlike most neuronal cell
populations in the mammalian nervous system, OSNs undergo apoptosis and
genesis throughout the life of the animal as part of the normal turnover
of mature OE. OSNs are unique in that they have relatively short
life spans compared with other neurons and are continuously being replaced
through basal cell proliferation and differentiation (neuronal regeneration) (Graziadei and Graziadei 1978). Most OSNs live for 30–40 days, but some cells have life spans
of 3 months or even longer. OSNs of laboratory animals may be induced
to die in vivo by experimentally manipulative methods that include olfactory bulbectomy, transection
of the olfactory nerve at the cribiform plate, and intranasal
exposure to chemicals known to be toxic to the OE, such as zinc
sulfate and methyl bromide (Cowan and Roskams 2002). Exposures to most olfactory chemical toxins result in necrosis (oncosis) of
the OSNs along with other epithelial cells in the OE, unlike the
selective cell death of OSNs by apoptosis observed in the present study. Recently, however, exposure of mice to some chemotherapeutic agents, such
as vincristine, was found to induce marked apoptosis of OSNs
with subsequent OE atrophy that resembles SG-induced lesions described
herein but without obvious nasal inflammation (Kai et al. 2004). In contrast to our study, mice in these previous studies were given
the chemical agents systemically and at much higher doses relative to
body weight (milligrams per kilogram vs. micrograms per kilogram). SG might drive both extrinsic (death receptor–mediated) and intrinsic (mitochondrial-mediated) apoptotic pathways in OSNs. The trichothecenes
induce gene expression and apoptosis via a ribotoxic stress response
that involves MAPKs (Shifrin and Anderson 1999; Yang et al. 2000) and is mediated upstream by double-stranded RNA–activated protein
kinase (Zhou et al. 2003) and Src-family kinases (Zhou et al. 2005b). Notably, SG-induced genes that have previously been associated with
death receptor–mediated OSN apoptosis include TNF-α, Fas, FasL, and p75NGFR (Cowan and Roskams 2002), as well as the downstream apoptotic genes p53 (Huang et al. 1995), Bax (Ge et al. 2002), and caspase-3 (Cowan and Roskams 2004). Relative to the intrinsic pathway, trichothecene deoxynivalenol induces
p38-mediated mitochondrial-dependent caspase-3 activation and apoptosis
in cloned macrophages (Zhou et al. 2005a). Furthermore, satratoxin H–induced caspase-3 activation and apoptosis
in the PC12 neural cell model have recently been reported to
be both p38 and JNK dependent (Nusuetrong et al. 2005). It is unclear why SG specifically targeted OSNs when nasal respiratory
epithelium and other cell types in the OE were unaffected. OSN sensitivity
to SG might relate to longer regional exposure to epithelial cells
in OE compared with the exposure to cells in respiratory epithelium. This
is possibly due to a much slower rate of mucociliary clearance of
inhaled agents from OE-lined ethmoid turbinates, which are covered by
immotile cilia, compared with other parts of the nasal cavity that are
lined by respiratory epithelium containing motile cilia with high ciliary
beat frequencies. This latter movement generates rapid regional
flows of mucus out of the nasal cavity and through the nasopharynx into
the upper digestive tract (Morgan et al. 1984). A slower rate of intranasal SG clearance from OE compared with respiratory
epithelium may also be due to differences in other factors known
to affect the clearance of chemicals from the nasal airway, such as
mucosal metabolism or blood flow. Alternatively, based on our observations that satratoxin-induced OE atrophy
is highly dependent on chemical structure (Figure 5 Taken together, our observations that the OE and OB are targets of SG and
ISF should be a critical consideration in future studies of damp-building–related
illnesses and the potential etiologic role of S. chartarum. The profile of induced cytokines and MIP-2 is likely to contribute to OSN apoptosis as well as accompanying rhinitis
and mild focal encephalitis observed in the present study. In the
future, it will be necessary to ascertain the dose–response effects
and latency of recovery in nasal tissue after chronic exposure to
satratoxins alone, as well as the contributions of spore matrix, or
coexposures to other indoor air contaminants such as endotoxin. Particularly
intriguing will be understanding the basis for OSN specificity
and the role of toxin metabolism. Of further critical importance will
be the extent to which toxicant-induced inflammation and neuronal injury
occur in other parts of the brain along the olfactory pathway and whether
this contributes to neurocognitive dysfunction. Ultimately, all
such information must be framed against accurate quantitative assessments
of human exposure to satratoxins using both state-of-the-art sampling
and analytical methods and relevant biomarkers. Footnotes We thank L. Bramble, M. Perry, A. Porter, R. Rosebury, K. Campbell, R. Common, D. Craft, L. Chen, B. Chamberlin, and A. Thelen for their technical
assistance. This research was funded by a Michigan State University Foundation Strategic
Partnership Grant, the Michigan State Health and Biomedical Research
Initiative I, and U.S. Public Health Service grant ES03358 (J.J.P.) from
the National Institute of Environmental Health Sciences. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||||||||||
Fungal Genet Biol. 2003 Jul; 39(2):103-17.
[Fungal Genet Biol. 2003]J Allergy Clin Immunol. 2004 Feb; 113(2):200-8; quiz 209.
[J Allergy Clin Immunol. 2004]J Occup Environ Med. 2003 May; 45(5):470-8.
[J Occup Environ Med. 2003]J Toxicol Environ Health A. 2003 Feb 28; 66(4):379-91.
[J Toxicol Environ Health A. 2003]Toxicol Appl Pharmacol. 2000 Apr 15; 164(2):149-60.
[Toxicol Appl Pharmacol. 2000]Appl Environ Microbiol. 1999 Jan; 65(1):88-94.
[Appl Environ Microbiol. 1999]J Urban Health. 2000 Mar; 77(1):68-85.
[J Urban Health. 2000]Toxicol Pathol. 2004 Jan-Feb; 32(1):26-34.
[Toxicol Pathol. 2004]Toxicol Pathol. 1991; 19(4 Pt 1):321-36.
[Toxicol Pathol. 1991]Neuroscience. 2004; 123(4):907-17.
[Neuroscience. 2004]Toxicol Sci. 2004 Jun; 79(2):315-25.
[Toxicol Sci. 2004]J Immunol. 2001 Sep 15; 167(6):3293-9.
[J Immunol. 2001]Toxicol Appl Pharmacol. 2000 Apr 15; 164(2):149-60.
[Toxicol Appl Pharmacol. 2000]Methods Mol Biol. 2001; 157():173-94.
[Methods Mol Biol. 2001]Analyst. 1998 Sep; 123(9):1835-41.
[Analyst. 1998]Am J Respir Cell Mol Biol. 1995 Mar; 12(3):307-14.
[Am J Respir Cell Mol Biol. 1995]Toxicol Pathol. 1994 Jul-Aug; 22(4):353-72.
[Toxicol Pathol. 1994]Fundam Appl Toxicol. 1981 Jul-Aug; 1(4):309-12.
[Fundam Appl Toxicol. 1981]Toxicol Pathol. 1991; 19(4 Pt 1):428-46.
[Toxicol Pathol. 1991]Toxicol Appl Pharmacol. 1994 Jul; 127(1):124-31.
[Toxicol Appl Pharmacol. 1994]Clin Sci (Lond). 2003 Apr; 104(4):389-95.
[Clin Sci (Lond). 2003]J Neurosci. 1984 Mar; 4(3):868-79.
[J Neurosci. 1984]Adv Appl Microbiol. 2004; 55():241-73.
[Adv Appl Microbiol. 2004]Toxicol Appl Pharmacol. 1990 Nov; 106(2):222-33.
[Toxicol Appl Pharmacol. 1990]Microsc Res Tech. 2002 Aug 1; 58(3):204-15.
[Microsc Res Tech. 2002]Toxicol Pathol. 2004 Nov-Dec; 32(6):701-9.
[Toxicol Pathol. 2004]J Biol Chem. 1999 May 14; 274(20):13985-92.
[J Biol Chem. 1999]Toxicol Appl Pharmacol. 2000 Apr 15; 164(2):149-60.
[Toxicol Appl Pharmacol. 2000]Toxicol Sci. 2003 Aug; 74(2):335-44.
[Toxicol Sci. 2003]Toxicol Sci. 2005 Jun; 85(2):916-26.
[Toxicol Sci. 2005]Microsc Res Tech. 2002 Aug 1; 58(3):204-15.
[Microsc Res Tech. 2002]Am Rev Respir Dis. 1984 Aug; 130(2):275-81.
[Am Rev Respir Dis. 1984]Cell. 1993 May 7; 73(3):597-609.
[Cell. 1993]